Cancer vaccinesPARDOLL, D. M.Immunology today (Amsterdam. Regular ed.). 1993, Vol 14, Num 6, pp 310-316, issn 0167-5699Article

Lymphoid reconstitution after transplantation of congenic hematopoietic cells in Busulfan-treated miceYEAGER, A. M; SHINN, C; PARDOLL, D. M et al.Blood. 1991, Vol 78, Num 12, pp 3312-3316, issn 0006-4971Article

Molecular and cellular events of T cell developmentFOWLKES, B. J; PARDOLL, D. M.Advances in immunology. 1989, Vol 44, pp 207-264, issn 0065-2776, 58 p.Article

Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic miceURDAHL, K. B; PARDOLL, D. M; JENKINS, M. K et al.The Journal of immunology (1950). 1994, Vol 152, Num 6, pp 2853-2859, issn 0022-1767Article

Hematopoietic cell transplantation in the twitcher mouse : the effects of pretransplant conditioning with graded doses of busulfanYEAGER, A. M; SHINN, C; SHINOHARA, M et al.Transplantation. 1993, Vol 56, Num 1, pp 185-190, issn 0041-1337Article

The fate of CD4^-8^- T cell receptor-αβ⁺ thymocytesLEVITSKY, H. I; GOLUMBEK, P. T; PARDOLL, D. M et al.The Journal of immunology (1950). 1991, Vol 146, Num 4, pp 1113-1117, issn 0022-1767, 5 p.Article

Deletion of self-reactive thymocytes occurs at a CD4⁺8⁺ precursor stageFOWLKES, B. J; SCHWARTZ, R. H; PARDOLL, D. M et al.Nature (London). 1988, Vol 334, Num 6183, pp 620-623, issn 0028-0836Article

A murine thymocyte clone expressing γδ T cell receptor mediates natural killer-like cytolytic function and TH1-like lymphokine productionSAITO, T; PARDOLL, D. M; FOWLKES, B. J et al.Cellular immunology (Print). 1990, Vol 131, Num 2, pp 284-301, issn 0008-8749Article

Self-reactive T cells are present in the peripheral lymphoid tissues of cyclosporin A-treated miceURDAHL, K. B; PARDOLL, D. M; JENKINS, M. K et al.International immunology. 1992, Vol 4, Num 12, pp 1341-1349, issn 0953-8178Article

Effects of cyclosporine A on T cell development and clonal deletionJENKINS, M. K; SCHWARTZ, R. H; PARDOLL, D. M et al.Science (Washington, D.C.). 1988, Vol 241, Num 4873, pp 1655-1658, issn 0036-8075Article

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumorsHONGXIU JI; WANG, T.-L; CHEN, C.-H et al.Human gene therapy. 1999, Vol 10, Num 17, pp 2727-2740, issn 1043-0342Article

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transferSIMONS, J. W; JAFFEE, E. M; HAUDA, K. M et al.Cancer research (Baltimore). 1997, Vol 57, Num 8, pp 1537-1546, issn 0008-5472Article

Selective association between MHC class I-restricted T cell receptors , CD8, and activated tyrosine kinases on thymocytes undergoing positive selectionCARRERA, A. C; SIOK-BI WEE; ROBERTS, T. M et al.The Journal of immunology (1950). 1992, Vol 149, Num 10, pp 3142-3149, issn 0022-1767Article

Activation properties of T cell receptor-γδ hybridomas expressing diversity in both γ- and δ-chainsMARUSIC-GALESIC, S; PARDOLL, D. M; SAITO, T et al.The Journal of immunology (1950). 1988, Vol 140, Num 2, pp 411-418, issn 0022-1767, 8 p.Article

Early genetic events in T cell development analyzed by in situy hybridizationPARDOLL, D. M; FOWLKES, B. J; LECHLER, R. I et al.The Journal of experimental medicine. 1987, Vol 165, Num 6, pp 1624-1638, issn 0022-1007Article

Treament of liver metastases from colon carcinoma with autologous tumor vaccine expressing granulocyte-macrophage colony-stimulating factorKWANG WOOK SUH; PIANTADOSI, S; YAZDI, H. A et al.Journal of surgical oncology. 1999, Vol 72, Num 4, pp 218-224, issn 0022-4790Article

Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. CommentaryOSHIRO, E. M; HOFFMAN, P. A; DIETSCH, G. N et al.Stroke (1970). 1997, Vol 28, Num 10, pp 2031-2038, issn 0039-2499Article

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigenKEN-YU LIN; GUARNIERI, F. G; STAVELEY-O'CARROLL, K. F et al.Cancer research (Baltimore). 1996, Vol 56, Num 1, pp 21-26, issn 0008-5472Article

Controlled release, biodegradable cytokine depots : a new approach in cancer vaccine designGOLUMBEK, P. T; AZHARI, R; JAFFEE, E. M et al.Cancer research (Baltimore). 1993, Vol 53, Num 24, pp 5841-5844, issn 0008-5472Article

Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccinesGOLUMBEK, P. T; HAMZEH, F. M; JAFFEE, E. M et al.Journal of immunotherapy. 1992, Vol 12, Num 4, pp 224-230, issn 1053-8550Article

Tyrosine kinase triggering in thymocytes undergoing positive selectionCARRERA, A. C; BAKER, C; ROBERTS, T. M et al.European journal of immunology. 1992, Vol 22, Num 9, pp 2289-2294, issn 0014-2980Article

Interleukin-2 production by tumor cells bypasses T Helper function in the generationh of an antitumor responseFEARON, E. R; PARDOLL, D. M; ITAYA, T et al.Cell (Cambridge). 1990, Vol 60, Num 3, pp 397-403, issn 0092-8674Article

Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancerO'MALLEY, B. W; DAQING LI; BUCKNER, A et al.The Laryngoscope. 1999, Vol 109, Num 3, pp 389-395, issn 0023-852XArticle

Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumorsSAMPATH, P; HANES, J; DIMECO, F et al.Cancer research (Baltimore). 1999, Vol 59, Num 9, pp 2107-2114, issn 0008-5472Article

Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumorsTHOMPSON, R. C; PARDOLL, D. M; JAFFEE, E. M et al.Journal of immunotherapy with emphasis on tumor immunology. 1996, Vol 19, Num 6, pp 405-413, issn 1067-5582Conference Paper